Silodosin | Annual Sales Report | Pharmacompass.com

Please Wait

Applying Filters...

Silodosin

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

63 API Suppliers, 16 USDMF, 6 JDMF, 12 EU WC, 11 KDMF, 7 NDC API, 46 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

INTERMEDIATES

23 Intermediate Suppliers

23 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

106 FDF Dossiers, 26 FDA Orange Book, 52 Europe, 8 Canada, 4 Australia, 2 South Africa, 14 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 4MG, CAPSULE;ORAL - 8MG

DIGITAL CONTENT

20 NEWS #PharmaBuzz

20 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 44 Finished Drug Prices, 7 Annual Reports

MARKET PLACE

21 APIs, 3 FDF Dossiers

PATENTS & EXCLUSIVITIES

6 Health Canada Patents

6 Health Canada Patents

REF. STANDARDS & IMPURITIES

7 Others

7 Others

$ Xls

Filters

Filters

FILTER :

filter Product Reset all filters

7 All

01 4Rapaflo

02 3Urief

List of Suppliers

Product Main Page

01

Brand Name : Rapaflo

PharmScience R&D

Not Confirmed

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Main Therapeutic Indication : Renal Disorders

Currency : USD

2017 Revenue in Millions : 115

2016 Revenue in Millions : 122

Growth (%) : -6

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Brand Name : Rapaflo

BioAsia

Not Confirmed

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Main Therapeutic Indication : Renal Disorders

Currency : USD

2018 Revenue in Millions : 88

2017 Revenue in Millions : 115

Growth (%) : -23%

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Brand Name : Rapaflo

BioAsia

Not Confirmed

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Main Therapeutic Indication : Renal Disorders

Currency : USD

2016 Revenue in Millions : 122

2015 Revenue in Millions : 126

Growth (%) : -3

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Brand Name : Rapaflo

BioAsia

Not Confirmed

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Main Therapeutic Indication : Nephrology

Currency : USD

2019 Revenue in Millions : 30

2018 Revenue in Millions : 88

Growth (%) : -67

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Brand Name : Urief

BioAsia

Not Confirmed

06

Brand Name : Urief

BioAsia

Not Confirmed

07

Brand Name : Urief

BioAsia

Not Confirmed

Contact us
to update this info